Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon

胡育文 (Yu-Wen Hu)


  • 學歷
    • 國立陽明交通大學 公共衛生研究所 博士
    • 國立陽明大學 醫學系 醫學士
  • 經歷
    • 2023- 迄今 臺北榮民總醫院 重粒子及放射腫瘤部 主治醫師
    • - 迄今 國立陽明大學 醫學系 兼任講師
    • - 臺北榮民總醫院 腫瘤醫學部 放射腫瘤科 主治醫師
    • - 臺北榮民總醫院 腫瘤醫學部 住院總醫師
  • 醫療專長
    1. 頭頸癌、鼻咽癌、肺癌、生殖泌尿道腫瘤、婦科腫瘤等放射治療、粒子放射治療
  • 證照



  1. Lai TY, Hu YW*.  Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction.  J Clin Oncol 2017 May; 35(14): 1623. Epub 2017 Jan. (IF: 24.008; Oncology 5/217)

  2. Wang TH*, Hu YW*.  Benefit of Adjuvant Therapy in Postoperative Early-Stage Small-Cell Lung Cancer: Is There Sufficient Evidence?.  J Clin Oncol 2017 Jan; 35(1): 117. Epub 2016 Oct. (IF: 24.008; Oncology 5/217)

  3. Hu YW.  Real-World Role of Adjuvant Chemotherapy in Bladder Cancer.  J Clin Oncol 2016 Sep; 34(26): 3224. Epub 2016 Jul. (IF: 20.982; Oncology 5/213)

  4. Hu YW.  Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016; 69: 50-7.  Eur Urol 2016 Dec; 70(6): e158. Epub 2016 May. (IF: 14.976; Urology & Nephrology 1/77)

  5. Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.  Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nation-Wide Population-Based Study.  J Natl Cancer Inst 2015 Nov; 108(2): djv314. (IF: 11.37; Oncology 9/213)

  6. Hu YW*.  Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients.  Am J Gastroenterol 2016 Nov; 111(11): 1655. (IF: 10.383; Gastroenterology & Hepatology 6/79)

  7. Hu YW.  Chinese Herbal Medicine Use and Risk of End-Stage Renal Disease in Patients with Chronic Kidney Disease: Is There An Immortal Time Bias?.  Kidney Int 2016 Jul; 90(1): 227-8. (IF: 7.683; Urology & Nephrology 4/77)

  8. Chen KT, Hu YW.  Letter: Risk of Breast Cancer in Patients with Thyroid Cancer Receiving I-131 Treatment: Is There An Immortal Time Bias?.  J Nucl Med 2016 Aug; 57(8): 1324. (IF: 5.849; Radiology, Nuclear Medicine & Medical Imaging 3/124)

  9. Lee PC, Hu YW, Hu LY, Chen SC, Chien SH, Shen CC, Yeh CM, Chen CC, Lin HC, Yen SH, Tzeng CH, Chen TJ, Liu CJ*.  Risk of Cancer in Patients with Cholecystitis: A Nation-Wide Population-Based Study.  Am J Med 2015 Feb; 128(2): 185-91. (IF: 5.61; Medicine, General & Internal 14/155)

  10. Hu YW.  Statins and the Risk of Pancreatic Cancer in Type 2 Diabetic Patients: Immortal Time Bias in Survival Analysis?.  Int J Cancer 2016 Jul; 139(1): 232. (IF: 5.531; Oncology 29/213)

  11. Lai TY, Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW*.  Risk Factors for Osteonecrosis of the Jaw in Oral Cancer Patients after surgery and Eventual Adjuvant Treatment: The Potential Role of Chemotherapy.  Radiother Oncol 2017 Jun; 123(3): 406-11. Epub 2017 May. (IF: 4.328; Radiology, Nuclear Medicine & Medical Imaging 13/126; Oncology 58/217)

  12. YW Hu, CM Yeh, CJ Liu, TJ Chen, N Huang, YJ Chou*.  Adapted Diabetes Complications Severity Index and Charlson Comorbidity Index in Predicting All-Cause and Cause-Specific Mortality Among Patients with Type 2 Diabetes.  BMJ Open Diabetes Res Care 2023 Mar; 11(2): e003262. (IF: 4.1; Endocrinology & Metabolism 58/184)

  13. Hung YP, Hu YW, Liu CJ*, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Chen SA, Albert CM, Chao TF*.  Risk and Predictors of Subsequent Cancers of Patients with Newly-Diagnosed Atrial Fibrillation - A Nationwide Population-Based Study.  Int J Cardiol 2019 Dec; 296: 81-6. Epub 2019 Aug. (IF: 3.471; Cardiac & Cardiovascular Systems 48/136)

  14. Su VY, Liu CJ, Chen YM, Chou TY, Chen TJ, Yen SH, Chiou TJ, Liu JH, Hu YW*.  Risk of Second Primary Malignancies in Lung Cancer Survivors - the Influence of Different Treatments.  Target Oncol 2017 Apr; 12(2): 219-27. Epub 2016 Oct. (IF: 3.438; Oncology 87/217)

  15. Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW*.  Risk Factors for and the role of Dental Extractions in Osteoradionecrosis of the Jaws: A National-Based Cohort Study.  Head Neck 2017 Jul; 39(7): 1313-21. Epub 2017 Mar. (IF: 3.376; Otorhinolaryngology 1/42; Surgery 34/196)

  16. Kang YM, Chao TF, Wang TH*, Hu YW*.  Increased Risk of Pelvic Fracture after Radiotherapy in Rectal Cancer Survivors: A Propensity Matched Study.  Cancer Med 2019 Jul; 8(8): 3639-47. Epub 2019 May. (IF: 3.357; Oncology 98/230)

  17. Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW*.  Second Primary Malignancy Risk after Radiotherapy in Rectal Cancer Survivors.  World J Gastroenterol 2018 Oct; 24(40): 4586-95. (IF: 3.3; Gastroenterology & Hepatology 35/80)

  18. Yang WC, Yen HJ, Liang ML, Chen HH, Lee YY, Chang FC, Lin SC, Wong TT, Hu YW*, Chen YW*.  Effect of Early Radiotherapy Initiation and High-Dose Chemotherapy on the Prognosis of Pediatric Atypical Teratoid Rhabdoid Tumors in Different Age Groups.  J Neurooncol 2020 May; 147(3): 619-31. Epub 2020 Mar. (IF: 3.267; Clinical Neurology 69/204; Oncology 126/244)

  19. YJ Lin, YM Kang, YH Wu, YW Chen, YW Hu*.  Lymphocytopenia and Survival After Whole-Brain Radiotherapy in Patients with Small-Cell Lung Cancer.  Thorac Cancer 2023 May; 14(14): 1268-75. Epub 2023 Mar. (IF: 2.9; Respiratory System 49/101; Oncology 175/318)

  20. Chiang CL, Hu YW, Wu CH, Chen YT, Liu CJ, Luo YH, Chen YM, Chen TJ, Su KC, Chou KT.  Spectrum of Cancer Risk Among Taiwanese with Chronic Obstructive Pulmonary Disease.  Int J Clin Oncol 2016 Oct; 21(5): 1014-20. (IF: 2.064; Oncology 156/217)

  21. Lin ST, Wang TH, Shiau CY, Liu YM, Chen TJ*, Hu YW*.  整合多套放射腫瘤與醫療資訊系統以實現病歷電子化 Integration of Multiple Radiation Oncology and Health Information Systems to Implement Computerization of Medical Records.  Therapeutic Radiology and Oncology 2018 Mar; 25(1): 21-32. (IF: -)

  22. TY Lai, TF Chao, TJ Chen, YM Liu, YW Hu.  蟹足腫病患之癌症風險以及與放射治療的相關性 The Risk of Cancer in Patients with Keloid and the Association with Radiotherapy.  Therapeutic Radiology and Oncology 2017 Dec; 24(4): 279-91. (IF: -)